Loading...
Loading...
India's ramipril imports from BULGARIA total $849 across 8 shipments from 1 foreign suppliers. BALKANPHARMA-DUPNITSA AD leads with $849 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for ramipril — a concentrated sourcing relationship with select suppliers from BULGARIA.

BALKANPHARMA-DUPNITSA AD is the leading Ramipril supplier from BULGARIA to India, with import value of $849 across 8 shipments. The top 5 suppliers — BALKANPHARMA-DUPNITSA AD — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BALKANPHARMA-DUPNITSA AD | $849 | 8 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED | $849 | 8 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Ramipril suppliers from BULGARIA to India include BALKANPHARMA-DUPNITSA AD. The leading supplier is BALKANPHARMA-DUPNITSA AD with import value of $849 USD across 8 shipments. India imported Ramipril worth $849 USD from BULGARIA in total across 8 shipments.
India imported Ramipril worth $849 USD from BULGARIA across 8 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Ramipril sourced from BULGARIA include ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED. The largest buyer is ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED with $849 in imports across 8 shipments.
The total value of Ramipril imports from BULGARIA to India is $849 USD, across 8 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
8 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists